Review: Inhaled insulin provides better glycemic control than oral hypoglycemic agents but not better than subcutaneous insulin
- Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes. DEFRONZO, RALPH A.; ELDOR, ROY; ABDUL-GHANI, MUHAMMAD // Diabetes Care;Aug2013 Supplement, Vol. 36 Issue S2, pS127
The article discusses a study on pathophysiologic approach to treatment for type 2 diabetes mellitus (T2DM). This approach uses initial combination therapy with agents known to correct established pathophysiologic defects in T2DM. It is stated that in this approach, the choice of anti-diabetes...
- Strategies for insulin impairment. R.M.D. // Cortlandt Forum;2/25/96, Vol. 9 Issue 2, p124
Responds to queries on efficacy of prescribing hypoglycemic agents among non-insulin dependent diabetics. Insulin levels; Recommendations for alternative medication regimen including exercise and proper diet.
- Higher liver transaminase levels and oral hypoglycemic drug therapy failure in patients with type 2 diabetes: is iron the missing link? Mascitelli, Luca; Goldstein, Mark // Acta Diabetologica;Dec2011, Vol. 48 Issue 4, p355
A letter to the editor is presented in response to the article "Transaminase levels in the upper normal range are associated with oral hypoglycemic drug therapy failure in patients with type 2 diabetes," by C. Irace and colleagues in the 2011 issue.
- VITAL: Paricalcitol reduced renal, CV risks in patients with diabetic nephropathy. // Endocrine Today;Jan2011, Vol. 9 Issue 1, p24
This article discusses the effectiveness of the combination of paricalcitol and renin-angiotension-aldosterone system inhibition in lowering residual renal risk for patients with type 2 diabetes.
- Type 2 diabetes in adults. Martyn, Annette // Nursing Standard;4/5/2006, Vol. 20 Issue 30, p67
The article reflects on how a British nurse gained the confidence to discuss medicine regimen with her type 2 diabetes patients through an article by H.M. Lakka and colleagues. The article is relevant to the nurse's practice because she is undertaking a post-registration course in diabetes. The...
- Notice of redundant publication. Porta, Massimo; Pozza, Guido; Lauro, Renato // Acta Diabetologica;Apr2014, Vol. 51 Issue 2, p313
A correction to the article "A nomogram to estimate the proportion of patients at haemoglobin A1c target\7 percent with noninsulin antidiabetic drugs in type 2 diabetes: a systematic review of 137 randomized controlled trials" that was published in the January 28, 2012 issue is presented.
- Screening for Silent Coronary Heart Disease in Type 2 Diabetes. Kharlip, Julia; Naglieri, Rosalie; Mitchell, Braxton D.; Ryan, Kathleen A.; Donner, Thomas W. // Diabetes Care;Mar2006, Vol. 29 Issue 3, p692
Presents a study which determined the proportion of patients in a clinical setting with type 2 diabetes. Research design and methods used; Statistical analysis of patients' data; Risk factor profile of patients.
- The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study. Mahrooz, Abdolkarim; Parsanasab, Hassan; Hashemi-Soteh, Mohammad; Kashi, Zahra; Bahar, Adele; Alizadeh, Ahad; Mozayeni, Maliheh // Clinical & Experimental Medicine;May2015, Vol. 15 Issue 2, p159
A major predicament in certain users of metformin, which is one of the most commonly used antihyperglycemic agents for type 2 diabetes (T2DM) treatment, is the lack of appropriate response to the drug. We evaluated the role of metformin response and OCT1 (organic cation transporter1) Met420del...
- Diabetes: Kicking off the insulin cascade. Jackson, Catherine // Nature;12/14/2006, Vol. 444 Issue 7121, p833
The article discusses the inhibition of the insulin-signaling pathway. It has been noted that the inhibition of the insulin-signaling pathway leads to insulin resistance, an early step in the development of type 2 diabetes. Many of the vital cellular processes that were vital for human health...